In vivo and in vitro glioma cell killing induced by an adenovirus expressing both cytosine deaminase and thymidine kinase and its association with interferon-α

Journal of Neuropathology and Experimental Neurology

Volumn 58, Issue 8, 1999, Pages 847-858

  Wang, Zhao Hui ^a   Zagzag, David ^a   Zeng, Baijin ^a   Kolodny, Edwin H ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Adenovirus; Cytosine deaminase; Double gene therapy; Glioma; Interferon ; Thymidine kinase

Indexed keywords

ALPHA INTERFERON; CYTOSINE DEAMINASE; THYMIDINE KINASE;

ADENOVIRUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL KILLING; CONTROLLED STUDY; CYTOTOXICITY; GENE THERAPY; GLIOBLASTOMA; GROWTH INHIBITION; HERPES SIMPLEX VIRUS; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; TUMOR REGRESSION; TUMOR VOLUME;

EID: 0032781263     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005072-199908000-00007     Document Type: Article

References (51)

1. Barba D, Hardin J, Ray J, and Gage F.H. Thymidine kinase mediated killing of rat brain tumors. J Neurosurg 1993;79:729-35
2. Boviatsis E. J, Park J. S, Sena-Esteves, M, et al. Long-term survival of rats harboring brain neoplasms treated with ganciclovir and a herpes simplex virus vector that retains an intact thymidine kinase gene. Cancer Res 1994;54:5745-51
3. Ram Z, Culver K.W, Walbridge S, Blaese R.M, and Oldfield E. H. In situ retroviral-mediated gene transfer for the treatment of brain tumors in rats. Cancer Res 1993;53:83-88
4. Takamiya Y, Short M.P, Moolten, L, Fleet C, Mineta T, Breakefield X.O, and Martuza R.L. An experimental model of retrovirus gene therapy for malignant brain tumors. J Neurosurg 1993;79:104-10
5. Kramm C. M, Sena-Esteves M, Barnett F. H, et al. Gene therapy for brain tumors. Brain Pathol 1995;5:345-81
6. Rogulski K.R, Kim J.H, Kim S.H, and Freytag S.O. Glioma cells transduced with an Escherichia coli CD/HSV-1 TK fusion gene exhibit enhanced metabolic suicide and radiosensitivity. Hum. Gene Ther 1997;8:73-85
7. Wang Z.H, Samuels S, Gama Sosa M.A, Kolodny E.H. 5-fluorocytosine-mediated apoptosis and DNA damage in glioma cells engineered to express cytosine deaminase and their enhancement with interferon. J Neuro-Oncol 1998;36:219-29
8. Mullen C.A, Kilstrup M, and Blaese R. M. Transfer of the bacterial gene for cytosine deaminase to mammalian cells confers lethal sensitivity to 5-fluorocytosine: a negative selection system. Proc Natl Acad Sci USA. 1992;89:33-37
9. Harris J.D, Gutierrez A.A, Hurst H.C, Sikora K, Lemoine N.R. Gene therapy for cancer using tumor-specific prodrug activation. Gene Ther 1994;1:170-75
10. Hirschowitz E.A, Ohwada A, Pascal W.R, Russi T. J, and Crystal R. G. In vivo adenovirus-mediated gene transfer of the Escherichia coli cytosine deaminase gene to human colon carcinoma-derived tumors induces chemosensitivity to 5-fluorocytosine. Hum Gene Ther 1995;6:1055-63
11. Chen C.Y, Chang Y.N, Ryan P, Linscott M, Mcgarrity G. J, and Chiang Y. L. Effect of herpes simplex virus thymidine kinase expression levels on ganciclovir-mediated cytotoxicity and the "bystander effect". Hum Gene Ther 1995;6:1467-76
12. Colombo B.M, Benedetti S, Ottolenghi S, et al. The "bystander effect": Association of U-87 cell death with ganciclovir-mediated apoptosis of nearby cells and lack of effect in athymic mice. Hum Gene Ther 1995;6:763-72
13. Cool V, Pirotte B, Gérard C, et al. Curative potential of herpes simplex virus thymidine kinase gene transfer in rats with 9L gliosarcoma. Hum Gene Ther 1996;7:627-35
14. Namba H, Tagawa M, Iwadate Y, Kimura M, Sueyoshi K, and Sakiyama S. Bystander effect-mediated therapy of experimental brain tumor by genetically engineered tumor cells. Hum Gene Ther 1998;9:5-11
15. Grem J.L, van Groeningen C.J, Ismail A.A, Johnston P.G, Alexander H.R, and Allegra C.J. The role of interferon-α as a modulator of fluorouracil and leucovorin. Eur J Cancer 1995;31:1316-20
16. Kreuser E. D, Wadler S, and Thiel E. Biochemical modulation of cytotoxic drugs by cytokines: Molecular mechanisms in experimental oncology. Recent Results in Cancer Research 1995;139: 371-82
17. Freytag S.O, Rogulski K.R, Paielli D.L, Gilbert J.D, Kim J.H. A novel three-pronged approach to kill cancer cells selectively: Concomitant viral, double suicide gene, and radiotherapy. Hum Gene Ther 1998;9:1323-33
18. Uckert W, Kammertöns T, Haack K, Oin Z, Gebert J, Schendel D.J, and Blankenstein T. Double suicide gene (cytosine deaminase and herpes simplex virus thymidine kinase) but not single gene transfer allows reliable elimination of tumor cells in vivo. Hum Gene Ther 1998;9:855-65
19. Santodonato L, Ferrantini M, Gabriele L, et al. Cure of mice with established metastatic Friend leukemia cell tumors by a combined therapy with tumor cells expressing both interferon-α 1 and herpes simplex thymidine kinase followed by ganciclovir. Hum Gene Ther 1996;7:1-10
20. Nanni P, De Giovanni C, Nicoletti G, et al. The immune response elicited by mammary adenocarcinoma cells transduced with interferon-γ and cytosine deaminase genes cures lung metastases by parental cells. Hum Gene Ther 1998;9:217-24
21. McKnight S.L. and Gavis E.R. Expression of the herpes thymidine kinase gene in xenopus laevis oocytes: An assay for the study of deletion mutants constructed in vitro. Nucl Aci Res 1980; 8:5931-48
22. Smiley J.R, Wagner M.J, Summers W.P, and Summers W.C. Genetic and physical evidence for the polarity of transcription of the thymidine kinase gene of herpes simplex virus. Virology 1980;102: 83-93
23. Maniatis T, Fritsch E. F, and Sambrook J. Molecular Cloning: A laboratory manual, 2nd Ed, Cold Spring Harbor Laboratory, Cold Spring Harbor, New York, 1989
24. Melcher A, Todryk S, Hardwick N, Ford M, Jacobson M, Vile R.G. Tumor immunogenicity is determined by the mechanism of cell death via induction of heat shock protein expression. Nature Med 1998;4:581-87
25. Kramm C.M, Rainov N.G, Sena-Esteves M, et al. Long-term survival in a rodent model of disseminated brain tumors by combined intrathecal delivery of herpes vectors and ganciclovir treatment. Hum. Gene Ther 1996;7:1989-94
26. Dong Y, Wen P, Manome Y, et al. In vivo replication-deficient adenovirus vector-mediated transduction of the cytosine deaminase gene sensitizes glioma cells to 5-fluorocytosine. Hum Gene Ther 1996;7:713-20
27. Vincent A.J.P.E, Vogels R, Someren G.V, et al. Herpes simplex virus thymidine kinase gene therapy for rat malignant brain tumors. Hum Gene Ther 1996;7:197-205
28. Van Groeningen C, Ren F, Geoffroy F, Johnston P, Grem J. Effects of fluorouracil combined with interferons a and γ in human colon cancer cells. Proc Am. Assoc Cancer Res 1994;35:448
29. Karp J.E, Broder S. New directions in molecular medicine. Cancer Res 1994;54:653-65
30. Goodman J.C, Trask T.W, Chen S.H, et al. Adenoviral-mediated thymidine kinase gene transfer into the primate brain followed by systemic ganciclovir: pathologic, radiologic, and molecular studies. Hum Gene Ther 1996;7:1241-50
31. Freeman S. M, Abboud C. N, Whartenby K. A, et al. The "bystander effect": Tumor regression when a fraction of the tumor mass is genetically modified. Cancer Res 1993;53:5274-83
32. Huber B. E, Austin E. A, Good S. S, Knick V. C, Tibbels S, Richards C. A. In vivo antitumor activity of 5-fluorocytosine on human colorectal carcinoma cells genetically modified to express cytosine deaminase. Cancer Res 1993;53:4619-26
33. Huber B. E, Austin E. A, Richards C. A, Davis S. T, and Good S. S. Metabolism of 5-fluorocytosine to 5-fluorouracil in human colorectal tumor cells transduced with the cytosine deaminase gene: significant antitumor effects when only a small percentage of tumor cells express cytosine deaminase. Proc Natl Acad Sci USA 1994;91:8302-6
34. Consalvo M, Mullen C. A, Modesti A, et al. 5-fluorocytosine-induced eradication of murine adenocarcinomas engineered to express the cytosine deaminase suicide gene requires host immune competence and leaves an efficient memory. J Immunol 1995;154: 5302-12
35. Ohwada A, Hirschowitz E.A, and Crystal R.G. Regional delivery of an adenovirus vector containing the Escherichia coli cytosine deaminase gene to provide local activation of 5-fluorocytosine to suppress the growth of colon carcinoma metastatic to liver. Hum Gene Ther 1996;7:1567-76
36. Trinh Q.T, Austin E.A, Murray D.M, Knick V.C, and Huber B.E. Enzyme/prodrug gene therapy: comparison of cytosine deaminase/ 5-fluorocytosine versus thymidine kinase/ganciclovir enzyme/prodrug systems in a human colorectal carcinoma cell line. Cancer Res 1995;55:4808-12
37. Pazdur R, Bready B, and Moore Jr, D. F. Clinical trials of fluorouracil with α-interferon in advanced colorectal carcinomas. Semin. Oncol. 1991;18:67-70
38. Kirkwood J. M. Studies of interferons in the therapy of melanoma. Semin. Oncol. 1991;18:83-90
39. Meadows L.M, Walther P, and Ozer H. α-interferon and 5-fluorouracil: Possible mechanisms of antitumor action. Semin Oncol 1991;18:71-76
40. Golumbek P.T, Hamzeh F.M, Jaffee E.M, Levitsky H, Lietman P.S, Pardoll D.M. Herpes simplex-1 virus thymidine kinase gene is unable to completely eliminate live, nonimmunogenic tumor cell vaccines. J Immunother 1992;12:224-30
41. Kramm C. M, Rainov N. G, Sena-Esteves M, et al. Herpes vector-mediated delivery of marker genes to disseminated central nervous system tumors. Hum Gene Ther 1996;7:291-300
42. Mullen C.A, Coale M.M, Lowe R., Blaese R. M. Tumors expressing the cytosine deaminase suicide gene can be eliminated in vivo with 5-fluorocytosine and induce protective immunity to wild type tumor. Cancer Res 1994;54:1503-6
43. Samejima Y. and Meruelo D. Bystander killing induces apoptosis and is inhibited by forskolin. Gene Ther 1995;2:50-58
44. Neefe J.R. and John W. Mechanisms of interaction of interferon and 5-fluorouracil in solid tumors. Semin Oncol 1991;18:77-82
45. Buechner S.A, Wernli M, Harr T, Hahn S, Itin P, Erb P. Regression of basal cell carcinoma by intralesional interferon-alpha treatment is mediated by CD95 (Apo-1/Fas)-CD95 ligand-induced suicide. J Clin Invest 1997;100:2691-96
46. Zhou A, Paranjape J, Brown XL, et al. Interferon action and apoptosis are defective in mice devoid of 2′, 5′-oligoadenylate-dependent Rnase L. EMBO J 1997;16:6355-63
47. Geng Y, Yu D, Blatt L.M, Taylor M.W. Tumor suppressor activity of the human consensus type I interferon gene. Cytokines & Mol Ther 1995;1:289-300
48. Clemens M.J and Elia A. The double-stranded RNA-dependent protein kinase PKR: structure and function. J Interferon & Cytokine Res 1997;17:503-24
49. Selleri C, Sato T, Del Vecchio L, et al. Involvement of Fas-mediated apoptosis in the inhibitory effects of interferon-alpha in chronic myelogenous leukemia. Blood 1997;89:957-64
50. Imam H, Eriksson B, Lukinius A, et al. Induction of apoptosis in neuroendocrine tumors of the digestive system during treatment with somatostatin analogs. Acta Oncologica 1997;36:607-14
51. Kim JH, Kolozsvary A, Rogulski K, Khil MS, Brown SL, Freytag SO. Selective radiosensitization of 9L glioma in the brain transduced with double suicide fusion gene. Cancer J Sci Am 1998;4: 364-69